Teva Pharms. USA, Inc. v. Mylan Pharms. Inc.
| Decision Date | 29 June 2012 |
| Docket Number | Nos. 08 Civ. 7611 (BSJ) (AJP), 09 Civ. 8824 (BSJ) (AJP).,s. 08 Civ. 7611 (BSJ) (AJP), 09 Civ. 8824 (BSJ) (AJP). |
| Citation | Teva Pharms. USA, Inc. v. Mylan Pharms. Inc., 876 F.Supp.2d 295 (S.D. N.Y. 2012) |
| Parties | TEVA PHARMACEUTICALS USA, INC., et al., Plaintiffs, v. SANDOZ, INC., et al., Defendants. Teva Pharmaceuticals USA, Inc., et al., Plaintiffs, v. Mylan Pharmaceuticals Inc., et al., Defendants. |
| Court | U.S. District Court — Southern District of New York |
OPINION TEXT STARTS HERE
David M. Hashmall, Goodwin Procter, LLP, Elizabeth J. Holland, Miriam London Martinez, Steven Jeffrey Lee, Carolyn Anne Blessing, Patrice Polyxene Jean, Kenyon & Kenyon, Jeffrey A. Simes, Jonathan Aaron Auerbach, Joseph B. Crystal, Goodwin Procter, LLP, Brian Jeffrey Eutermoser, Weil, Gotshal & Manges LLP, New York, NY, Daryl L. Wiesen, John T. Bennett, Nicholas K. Mitrokostas, Goodwin Procter, LLP, Boston, MA, William G. James, II, Kenyon & Kenyon LLP, Washington, DC, for Plaintiffs.
Anders T. Aannestad, Brian Matthew Kramer, David C. Doyle, Morrison & Foerster LLP, San Diego, CA, Karen Louise Hagberg, Richard B. Mills-Robertson, Morrison & Foerster LLP, Andrew Levine, Friedman, Kaplan, Seiler & Adelman LLP, Beth D. Jacob, Schiff Hardin LLP, New York, NY, David L. Anstaett, Sarah C. Walkenhorst, Perkins Coie LLP, Madison, WI, Ricardo Solano, Jr., Friedman, Kaplan, Seiler & Adelman LLP, Newark, NJ, for Defendants.
Opinion and Order
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeStart Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial
13 cases
-
Janssen Prods., L.P. v. Lupin Ltd.
...is "an inextricable and essential part of what doctors are prescribing" when they prescribe Prezista. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 416–17 (S.D.N.Y.2012), aff'd, 723 F.3d 1363 (Fed.Cir.2013), cert. granted on other issues, ––– U.S. ––––, 134 S.Ct. 1761, 188 L.Ed......
-
AstraZeneca LP v. Breath Ltd.
...and effective drug often supports the nonobviousness of a drug that finally achieves success.” Teva Pharma. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 417 (S.D.N.Y.2012). AstraZeneca introduced evidence of its own failures to create the claimed budesonide compositions using conventional ......
-
Depomed, Inc. v. Actavis Elizabeth LLC
...the patents may be demonstrated by an ANDA filer's certification and Notice Letter to the patent holder. Teva Pham. U.S.A., Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 349 (S.D.N.Y 2012). In assessing whether an asserted noninfringing use is substantial, the factfinder considers not only the......
-
Chin–McKenzie v. Continuum Health Partners
... ... Inc. (“Continuum”) and Long Island College ... See Amnesty Int'l USA v. Clapper, 638 F.3d 118, 129 n. 13 (2d ... ...
Get Started for Free
1 firm's commentaries
-
Supreme Court To Consider Federal Circuit De Novo Review Of Claim Construction In Teva Pharmaceuticals USA Inc. V. Sandoz Inc.
...that a person of ordinary skill in the art would know to use the peak average molecular weight. Teva Pharm. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 400 -01 (S.D.N.Y. 2012) aff'd in part, rev'd in part, 723 F.3d 1363 (Fed. Cir. 2013) cert. granted, 13-854, 2014 WL 199529 (U.S. Mar. 3......
2 books & journal articles
-
Use of Reissue Proceedings in Hatch-Waxman Litigation
...found, again, that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine pa......
-
Use of Reissue Proceedings in Hatch-Waxman Litigation
...that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine patents, seven w......